Effect of herbal Formulation in dilated veins of legs

Efficacy of Sufoof-e-Chobchini in Chronic Venous Disease of Lower Limbs- A Randomized, Single-Blind, Placebo-Controlled Clinical Trial - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/068166

Enrollment

Registered

2024-05-31

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I831- Varicose veins of lower extremities with inflammation

Interventions

Intervention1: Sufoof-e-Chobchini: 5gm Sufoof-e-Chobchini will be given orally in capsule form in 3 divided doses daily for 8 weeks Control Intervention1: Placebo: Placebo (Wheat flour) 5gm will be gi

Eligibility

Inclusion criteria

Inclusion criteria: 1) Subjects having Chronic Venous Disease according to CEAP Clinical Classification (from class C1 To C4). 2) All Genders, Aged Between 20 to 60 Years. 3) Subjects willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Subjects with Uncontrolled Hypertension (Greater than 140/90) and Diabetes Mellitus (Greater than 7), and Acute Systemic illness. 2. Subjects with Past history of Varicose Vein Surgery and Varicose Ulcer. 3. Known cases of DVT or other secondary causes of CVD. 4. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
RVCSS[Revised venous clinical severity score]Timepoint: 0th day,2nd week,4th week,6th week,8th week	—

Secondary

Measure	Time frame
Quality of life questionnaire (CIVIQ)Timepoint: 0th day , 8th week	—

Countries

India

Contacts

Public ContactDr Faseeha Eram

National Institute of Unani Medicine, Kottigepalya Bengaluru Karnataka 560091

faseehaeram9@gmail.com8791701225

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026